why choose us

300×250 Ad Slot

Research Article: Nomogram incorporating log odds of positive lymph nodes improves prognostic prediction for ovarian serous carcinoma: a real-world retrospective cohort study

Date Published: 2023-10-21

Abstract:
Objectives Ovarian serous carcinoma (OSC) is a major cause of gynaecological cancer death, yet there is a lack of reliable prognostic models. To address this, we developed and validated a nomogram based on conventional clinical characteristics and log odds of positive lymph nodes (LODDS) to predict the prognosis of OSC patients. Setting A Real-World Retrospective Cohort Study from the Surveillance, Epidemiology and End Results programme. Participants We obtained data on 4192 patients diagnosed with OSC between 2010 and 2015. Eligibility criteria included specific diagnostic codes, OSC being the primary malignant tumour and age at diagnosis over 18 years. Exclusion criteria were missing information on various factors and unknown cause of death or survival time. Primary and secondary outcome measures The primary outcome were overall survival (OS) and ovarian cancer-specific survival (OCSS). Results For OS and OCSS outcomes, we selected 7 and 5 variables, respectively, to establish the nomogram. In the training and validation cohorts, the C index for OS or OCSS was 0.716 or 0.718 and 0.731 or 0.733, respectively, with a 3-year time-dependent area under the curve (AUC) of 0.745 or 0.751 and a 5-year time-dependent AUC of 0.742 or 0.751. Calibration curves demonstrated excellent consistency between predicted and observed outcomes. The Net Reclassification Index, integrated discrimination improvement and decision curve analysis curves indicated that our nomogram performed better than the International Federation of Gynaecology and Obstetrics (FIGO) staging system in predicting OS and OCSS for OSC patients in both the training and validation cohorts. Conclusion Our nomogram, which includes LODDS, offers higher accuracy and reliability than the FIGO staging system and can predict overall and OCSS in OSC patients.

Introduction:
Ovarian cancer is one of the three malignancies affecting the female reproductive system and has the highest mortality rate among gynaecological tumours. 1 According to American cancer statistics, approximately 19?880 new cases of ovarian cancer will be diagnosed in the USA in 2022, with 12?810 deaths anticipated. 2 The unique location of ovarian cancer and its inconspicuous early clinical symptoms make early detection challenging, resulting in over two-thirds of patients being diagnosed at advanced stages,…

Read more

300×250 Ad Slot